Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CANEXUS CORP 6.5 PCT DEBS T.CUS.DB.D

Chemicals Specialty Chemicals


TSX:CUS.DB.D - Post by User

CANEXUS CORP 6.5 PCT DEBS > "The due diligence undertaken by Chemtrade"
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(126)
•••
Comment by Khersonon Oct 25, 2016 7:27am
129 Views
Post# 25381349

RE:"The due diligence undertaken by Chemtrade"

RE:"The due diligence undertaken by Chemtrade" Actually, the offer is too generous! The book value for Canexus equity is actually less than zero. Keep in mind that Davis clearly points out that Canexus has a number of operational deficiencies and "catch up" costs that they need to pay! I wonder if the lawsuits are also considered part of those costs?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities